Insulet hires first chief R&D officer amid growing competition.
Article excerpt
Highlighted: the sentence this signal was extracted from
Insulet hires first chief R&D officer amid growing competition. Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company's innovation capabilities. Published June 23, 2026 Name: Divakar Ramakrishnan New title: Chief research and development officer, Insulet Previous title: Chief science, innovation and quality officer, Convatec Insulet hired Divakar Ramakrishnan as its first chief research and development officer, the company confirmed on Monday. Ramakrishnan will lead global product development and Insulet's research and development as it faces growing competition from other insulin pump makers. "This is an important milestone in our efforts to strengthen Insulet's innovation capabilities in support of accelerating our exciting pipeline to reach even more people with diabetes around the world," an Insulet spokesperson wrote in an emailed statement. Ramakrishnan announced the new job in a Monday LinkedIn post, adding that the strength of Insulet's product portfolio and pipeline drew him to the role. Ramakrishnan's background includes working at medical device firm Convatec as chief science, innovation and quality officer, according to his LinkedIn profile. Prior to working for Convatec, Ramakrishnan was chief digital officer at Eli Lilly. Insulet, which makes insulin patch pumps...
Keep reading with a free account
The rest of this article, and every signal for Insulet, is in your free account.
